deltatrials

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest Clinical Trials

Sponsors / Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest appears as lead sponsor on 46 trial records in ClinicalTrials.gov. Of these, 11 are recruiting, 8 are active without new recruitment, and 19 have completed. The registry records 6 terminated or withdrawn trials for Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest. The most common reasons cited for termination include slow or insufficient recruitment, efficacy or futility findings, business or strategic decisions. Planned participant enrollment across these trials sums to 15,491. Figures on this page are sourced from ClinicalTrials.gov and refreshed with each registry update.

46
Total Trials
11
Recruiting
8
Other Active
19
Completed
6
Terminated / Withdrawn
15,491
Total Enrollment

Termination reasons: Recruitment67% · Efficacy17% · Business17%

Recent Terminations

  • NCT05489250 Stopped Jun 2025
    Cholangiocarcinoma
    "Sponsor Decision"
  • NCT06050434 Stopped Jul 2024
    Soft Tissue Sarcoma
    "The study was terminated prematurely due to slow recruitment after inclusion of 7 patients (of initially planned 100 patients)."
  • NCT03164980 Phase PHASE4 Stopped Aug 2023
    Ovarian Cancer
    "A total of 204 patients were planned to be randomized. Due to slow recruitment of the trial, the recruitment was prematurely terminated after randomization of the 89th patient."
  • NCT04105777 Stopped Jan 2023
    Solid Tumor
    "Low recruitment"
  • NCT04147143 Stopped Feb 2021
    Advanced Renal Cell Carcinoma (All Subtypes)
    "Due to insufficient recruitment rate, recruitmend has been terminated after inclusion of 56 patients"
  • NCT03698227 Phase PHASE2 Stopped Jun 2020
    Advanced Soft Tissue Sarcoma
    "Lack of efficacy on olaratumab"

Active Trials (8 total)

Top Conditions

Cholangiocarcinoma (3) Biliary tract cancer (2) Colorectal cancer (2) Esophagogastric adenocarcinoma (2) Gastric cancer (2) Gastroesophageal junction cancer (2) Hepatocellular carcinoma (2) Hepatocellular carcinoma (hcc) (2) Metastatic colorectal cancer (2) Adenocarcinoma of the stomach (1)

Top Locations

Berlin, Germany (27) Frankfurt, Germany (23) München, Germany (21) Hamburg, Germany (18) Essen, Germany (17) Bad Saarow, Germany (15) Frankfurt am Main, Germany (15) Dresden, Germany (14) Heidelberg, Germany (14) Mainz, Germany (12)